This study investigated the effect of folic acid (B9) and vitamin B12 supplementation on lowering plasma total homocysteine (tHcy) levels in hemodialysis (HD) patients, specifically focusing on the impact of MTHFR (C677T) genotypes. It involved 132 HD patients who were randomized to receive B9, B12, or a combination of both
